Participation in the 36th International Congress of the Hellenic Society of Intraocular Implant and Refractive Surgery
Prof. Pallikaris along with EYE PCR team joined the 36th International Congress
Dr. Noguchi’s presentation on fixOflex at the 45th Annual Meeting of the Japanese Society of Ophthalmic Surgery
Dr. Santaro Noguchi the well-known japanese Ophthalmologist, who is conducting a study on the fixOflex, presented our product and results at the 45th Annual Meeting of the Japanese Society of Ophthalmic Surgery. For more details click here: https://www.jsos.jp/jsos45
Details
Participation in the Pallas Kliniken Ophthalmological Conference – OTO 2022
From January 27th to 29th 2022, the 27th Pallas Kliniken Ophthalmological Conference (OTO) took place with numerous highlights. The OTO is a three-day ophthalmologists’ congress that is now well-known throughout Switzerland. LASIK pioneer Ioannis Pallikaris talked about his new invention of the fixOflexTM implant. Click the link for more details: https://www.pallas-kliniken.ch/de/news/artikel/oto-2022-jetzt-anmelden
Details
Professor I. Pallikaris interview with Healio/OSN
Professor Pallikaris presents the fixOflex, the novel intraocular ring that enhances IOL stability and prevents PCO in an exclusive interview with Healio/OSN by Michela CImberle. The full interview can be accessed by clicking here.
Details
Participation in 39th ESCRS Congress – Amsterdam 8-11 October 2021
Professor Pallikaris joined the ESCRS Congress in Amsterdam presenting our product fixOflex and reporting our clinical experience with 108 patients from our clinical study in Alexandria of Egypt. You can visit ESCRS on Demand to watch recorded session from the Congress by clicking here.
Participation in ASCRS Congress July 2021
EYE-PCR is participating with a presentation of fixOflex using the early outcome of a cohort of 108 patients from the on going Clinical Trial in Alexandria, Egypt. The presentation can be accessed by clicking here.
Details
We are proud to announce that we have successfully integrated 120 cases in the clinical study of Alexandria site.
We are proud to announce that we have successfully integrated 120 cases in the clinical study of Alexandria site. The initial trial launched in December 2019 at the Alexandria University, Egypt with Principal Investigators: Prof. Ahmed Elmassry and Prof. Osama Ibrahim and with the objective to perform the fixOflexTM implantation and 12-month follow up in 120 patients.
Details
Initiation of the additional clinical trial at the University of Crete
On the 14th of May 2021 we have successfully initiated the additional trial that was planned at the University of Crete in Greece in which Principal Investigator is Prof. Efstathios Detorakis. The intention being for launching this extra clinical trial is to elaborate more on the clinical findings in a small number of patients.
Participation in ARVO Congress May 2021
EYE-PCR has presented a poster referring to the on going Clinical Trial in Alexandria. The early outcome of a cohort of 72 patients was promising. A video of Prof. Ioannis Pallikaris presenting the fixOflex Ring was released.
Preservation of capsular transparency and geometrical consistency in cataract surgery using a novel intracapsular ring.
We report a case of a patient that was implanted with an intracapsular ring during phacoemulsification cataract surgery. Namely, we report on refraction, posterior capsule transparency and IOL ACD and document photographically the appearance of the posterior capsule. It is suggested that the presence of the intracapsular ring has inhibited epithelial cell migration and prevented…
Details